In its various areas of specialisation, Laboratorios LETI aims to contribute to society, through products that add value to healthcare. In addition to effective treatments, LETI contributes to the sustainable improvement of health and wellbeing by paying attention to prevention, early diagnosis and specialised body care. In a society which is increasingly prosperous and with greater life expectancy, self-care, prevention and early diagnosis are essential and perfectly achievable, in order to maintain the public and private health systems.
Research and specialisation are critical elements in the strategy of Laboratorios LETI. Having innovative and patented products is essential to international growth in the selected market segments. For this reason, Laboratorios LETI devotes between 8 and 10 percent of its turnover to research and product development. While strategic planning and resource allocation to different research programs takes place at corporate level, implementation is the responsibility of the individual business units, with programs and resources commensurate with its objectives and strategies. Furthermore, the R&D departments play an important role in training Spanish, German, Portuguese and Latin American specialists. Immunology and biotechnology which are the roots of the company have been the platform for the diversification process into related fields.
Laboratorios LETI has a matrix structure based on products and geographical regions, which include the following business units: Allergy, Dermatology, Diagnostics and Immunology and Vaccines.
- The Allergy Unit specialises in the production of allergenic extracts for in vivo diagnosis and the aetiological treatment of allergies.
- The Dermatology Unit focuses on skin care and other products for specialised body care, all of which are available in chemists/pharmacies and generally under medical prescription.
- The Diagnostics Unit specializes in 'in vitro' diagnostics, culture media for assisted reproduction and vaccines.
- The Immunology and Vaccines Unit has the objective of promoting research and innovation discovering vaccines to prevent and alleviate diseases that affect people around the world.
It also has territorial units in Portugal and North and Central Europe. LETI Pharma GmbH, based in Witten (Germany), and Laboratorios LETI, Lda, based in Porto (Portugal).
All the above are supported by the following corporate departments: Legal, Finance and Administration, Innovation, Logistics and Human Resources.
It is the will of Laboratorios LETI is to count on a competitive team who are respected professionally and who share the company values, strategies and objectives. For that reason LETI proposes to be considered as an excellent work place. The prime responsibility of LETI´s directors and management is the development and management of their staff as well as sharing and implementing the strategies, objectives and policies of the company. From a commercial perspective, special attention is paid to the constant improvement of the company's competitive position and to the generation of free cash flow (FCF).
Laboratorios LETI is a founder member of Asebio (Spanish Association of Biocompanies) and EAMG (European Allergens Manufacturers Group), a member of Farmaindustria, FENIN (Spanish Federation of Healthcare Technology Companies) and BPI (Bundesverband der Industrie Pharmazeutischen). In addition, it donates to various charities and non-profit organizations in areas related to health and education.
